Paul Spector
Psychiatry · Richmond, VANPI 1134285927
Payments from drug & device makers
Across 243 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$543
- Teva Pharmaceuticals USA, Inc.$494
- Otsuka America Pharmaceutical, Inc.$491
- Idorsia Pharmaceuticals US Inc$129
- plus $799 from 13 others
What the payments were for
- Food & beverage$4,91797%
- Education$1563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 83 | $1,317 |
| AbbVie(2 entities) | 111 | $1,301 |
| Neurocrine Biosciences, Inc. | 12 | $543 |
| Teva Pharmaceuticals USA, Inc. | 5 | $494 |
| Otsuka America Pharmaceutical, Inc. | 8 | $491 |
| Idorsia Pharmaceuticals US Inc | 6 | $129 |
| Ironshore Pharmaceuticals Inc. | 1 | $125 |
| Harmony Biosciences LLC | 1 | $118 |
| Corium, LLC | 1 | $116 |
| Johnson & Johnson | 1 | $96 |
| Sunovion Pharmaceuticals Inc. | 5 | $92 |
| Amgen | 1 | $88 |
| Axsome Therapeutics, Inc. | 1 | $74 |
| Lundbeck LLC | 2 | $28 |
| Bausch Health US, LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Forte Bio-pharma LLC | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,073 in reported general payments places this provider in the 90th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HetliozTasimelteon | 15 | $358,932 |
| IngrezzaValbenazine Tosylate | 16 | $129,959 |
| AustedoDeutetrabenazine | 13 | $73,431 |
| RexultiBrexpiprazole | 26 | $43,918 |
| VraylarCariprazine Hcl | 26 | $38,866 |
| NuedextaDextromethorphan Hbr/Quinidine | 24 | $36,769 |
| GraliseGabapentin | 21 | $26,446 |
| CaplytaLumateperone Tosylate | 13 | $21,180 |
| NucyntaTapentadol Hcl | 24 | $17,984 |
| FetzimaLevomilnacipran Hcl | 13 | $17,770 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $14,878 |
| OxycontinOxycodone Hcl | 27 | $13,173 |
| Clozapine OdtClozapine | 11 | $11,659 |
| Vilazodone Hcl | 143 | $11,619 |
| TrintellixVortioxetine Hydrobromide | 17 | $10,751 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $543 | $129,95916 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $494 | $73,43113 claims |
| AbbVieVraylar, Fetzima, Viibryd | $1,301 | $63,28758 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $491 | $43,91826 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,317 | $21,18013 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $129 | $5,28011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 884 psychiatry providers in Virginia.
Other psychiatry in Richmond
- Frederick MoellerRichmond$678K
- Susan KornsteinRichmond$87K
- Ashvin PatelRichmond$68K
- Joel SteinbergRichmond$40K
- James SellmanRichmond$18K
- Robert SewardRichmond$14K
- William KernodleRichmond$14K
- John LeeRichmond$10K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.